Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Plasmacytoma of the ovary: additional role of 18F-FDG PET/CT.

Santhosh S, Mittal BR, Raveendran A, Jain V, Nijhawan R, Kumar R, Bhattacharya A, Sharma SC.

Clin Nucl Med. 2013 May;38(5):e230-2. doi: 10.1097/RLU.0b013e318253212d.

PMID:
23377413
2.

Gastric recurrence of a primary colon plasmacytoma: staging and evaluating response to therapy with 18F-FDG PET/CT.

Makis W, Ciarallo A, Hickeson M, Lisbona R.

Br J Radiol. 2012 Jan;85(1009):e4-9. doi: 10.1259/bjr/37953406.

3.

[18F-FDG PET/CT in patients, treated for ovarian cancer, with elevated CA 125 levels but no evidence of recurrence on conventional imaging].

Bochev P, Bocheva Y, Klisarova A, Ivanov S, Dancheva J, Chaushev B.

Akush Ginekol (Sofiia). 2012;51(1):18-27. Bulgarian. No abstract available.

PMID:
22639775
4.

A low F-18 FDG uptake in the nasopharynx plasmacytoma detected by FDG PET/CT.

Dong MJ, Liu ZF, Wang GL, Zhao K, Sun ML, Wang HT, Yang SY.

Clin Nucl Med. 2011 Nov;36(11):1053-5. doi: 10.1097/RLU.0b013e31821a2ae7. No abstract available.

PMID:
21975405
5.

FDG PET/CT in serous psammocarcinoma of the ovary.

Dong A, Wang Y, Zuo C.

Clin Nucl Med. 2014 May;39(5):453-5. doi: 10.1097/RLU.0b013e318286bdfc.

PMID:
23510884
6.

18F-FDG PET/CT Metabolic Activity in a Patient With Solitary Extramedullary Plasmacytoma of the Lung.

Zhang L, Zhang X, Zhang R, Fan W.

Clin Nucl Med. 2016 Mar;41(3):232-4. doi: 10.1097/RLU.0000000000001030.

PMID:
26462042
7.

18F-FDG PET/CT Demonstrated the Multiple Myeloma From Prostate.

Cheng A, Liping F, Wang X, Zhao L, Yang J.

Clin Nucl Med. 2016 Apr;41(4):328-30. doi: 10.1097/RLU.0000000000001045.

PMID:
26562573
8.

Solitary extramedullary plasmacytoma of the parotid gland imaged with 18F-FDG PET/CT.

Alabed YZ, Rakheja R, Laufer J.

Clin Nucl Med. 2014 Jun;39(6):549-50. doi: 10.1097/RLU.0b013e3182a75c95.

PMID:
24152625
9.

Assessment of ovarian teratoma and lymphadenopathy by 18F-FDG PET/CT.

Balink H, Apperloo MJ, Collins J.

Clin Nucl Med. 2012 Aug;37(8):804-6. doi: 10.1097/RLU.0b013e3182485361.

PMID:
22785518
10.

Leydig cell tumour of the ovary localised with positron emission tomography/computed tomography.

Prassopoulos V, Laspas F, Vlachou F, Efthimiadou R, Gogou L, Andreou J.

Gynecol Endocrinol. 2011 Oct;27(10):837-9. doi: 10.3109/09513590.2010.521263. Epub 2011 Jun 13.

PMID:
21668318
11.

[18F-FDG PET-CT in a case of solitary plasmacytoma of the soft palate].

Fernández López R, Borrego Dorado I, Paz Coll A, Vázquez Albertino R, Gómez Camarero P, Sanz Viedma S.

Rev Esp Med Nucl. 2010 Sep-Oct;29(5):263-5. doi: 10.1016/j.remn.2010.02.010. Spanish.

12.

Isolated splenic metastasis of ovarian cancer detected with 18F-FDG PET/CT.

Lee DH, Yoon JK, Lee SJ, Jo KS, Yoon SH, An YS.

Clin Nucl Med. 2014 Apr;39(4):349-51. doi: 10.1097/RLU.0b013e31828e9894.

PMID:
23640230
13.

Detection of nodal metastases by 18F-FDG PET/CT in apparent early stage ovarian cancer: a prospective study.

Signorelli M, Guerra L, Pirovano C, Crivellaro C, Fruscio R, Buda A, Cuzzucrea M, Elisei F, Ceppi L, Messa C.

Gynecol Oncol. 2013 Nov;131(2):395-9. doi: 10.1016/j.ygyno.2013.08.022. Epub 2013 Aug 27.

PMID:
23988414
14.

FDG-PET/CT as a molecular biomarker in ovarian cancer.

Nowosinska E, Avril S, Murray I, Szyszko T, Avril N.

Cancer Biomark. 2010-2011;8(4-5):167-75. doi: 10.3233/CBM-2011-0219. Review.

PMID:
22045351
15.

Prognostic significance of mediastinal 18F-FDG uptake in PET/CT in advanced ovarian cancer.

Bats AS, Hugonnet F, Huchon C, Bensaid C, Pierquet-Ghazzar N, Faraggi M, Lécuru F.

Eur J Nucl Med Mol Imaging. 2012 Mar;39(3):474-80. doi: 10.1007/s00259-011-1984-9. Epub 2011 Nov 23.

PMID:
22109667
16.

Solitary Plasmacytoma in the Renal Pelvis on 18F-FDG and 11C-Acetate PET/CT.

Hu G, Ma Y, Dang Y, Li F, Huo L.

Clin Nucl Med. 2016 May;41(5):407-9. doi: 10.1097/RLU.0000000000001141.

PMID:
26859204
17.

Utility of 18F-FDG PET/CT in follow-up of patients with low-grade serous carcinoma of the ovary.

Takeuchi S, Lucchini M, Schmeler KM, Coleman RL, Gershenson DM, Munsell MF, Macapinlac HA, Ramirez PT.

Gynecol Oncol. 2014 Apr;133(1):100-4. doi: 10.1016/j.ygyno.2014.02.008. Epub 2014 Feb 15.

18.

[Efficacy of serum immunoglobulin free light chain and 18F-FDG PET/CT for therapeutic evaluation in a case with multiple plasmacytoma of bone].

Inoue T, Nagai K, Momoi A, Isahai N, Sakai T, Sekiya M.

Rinsho Ketsueki. 2015 Apr;56(4):418-22. doi: 10.11406/rinketsu.56.418. Japanese.

PMID:
25971273
19.

¹⁸F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders.

Dammacco F, Rubini G, Ferrari C, Vacca A, Racanelli V.

Clin Exp Med. 2015 Feb;15(1):1-18. doi: 10.1007/s10238-014-0308-3. Epub 2014 Sep 14. Review.

PMID:
25218739
20.

Isolated adrenal metastasis of small cell neuroendocrine carcinoma of the ovary detected with FDG-PET/CT.

Ozpacaci T, Tamam MO, Mulazimoglu M, Kamali G, Ozcan D.

Rev Esp Med Nucl Imagen Mol. 2012 Sep;31(5):297-8. doi: 10.1016/j.remn.2011.10.004. Epub 2011 Nov 26. No abstract available.

Supplemental Content

Support Center